z-logo
Premium
Impact of deprivation on breast cancer survival among women eligible for mammographic screening in the West Midlands ( UK ) and New South Wales (Australia): Women diagnosed 1997–2006
Author(s) -
Woods Laura M.,
Rachet Bernard,
O'Connell Dianne,
Lawrence Gill,
Coleman Michel P.
Publication year - 2016
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.29983
Subject(s) - social deprivation , medicine , breast cancer , demography , cancer survival , cancer , cancer registry , breast cancer screening , mammography , sociology , economics , economic growth
Women diagnosed with breast cancer in the UK display marked differences in survival between categories defined by socio‐economic deprivation. Timeliness of diagnosis is one of the possible explanations for these patterns. Women whose cancer is screen‐detected are more likely to be diagnosed at an earlier stage. We examined deprivation and screening‐specific survival in order to evaluate the role of early diagnosis upon deprivation‐specific survival differences in the West Midlands (UK) and New South Wales (Australia). We estimated net survival for women aged 50–65 years at diagnosis and whom had been continuously eligible for screening from the age of 50. Records for 5,628 women in West Midlands (98.5% of those eligible, mean age at diagnosis 53.7 years) and 6,396 women in New South Wales (99.9% of those eligible, mean age at diagnosis 53.8 years). In New South Wales, survival was similar amongst affluent and deprived women, regardless of whether their cancer was screen‐detected or not. In the West Midlands, there were large and persistent differences in survival between affluent and deprived women. Deprivation differences were similar between the screen‐detected and non‐screen detected groups. These differences are unlikely to be solely explained by artefact, or by patient or tumour factors. Further investigations into the timeliness and appropriateness of the treatments received by women with breast cancer across the social spectrum in the UK are warranted.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here